Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mebendazole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mebendazole 100mg/5ml oral suspension
0505010D0AAAAAA
|
Mebendazole | Mebendazole | Infections | 14,977 |
|
Mebendazole 100mg chewable tablets sugar free
0505010D0AAADAD
|
Mebendazole | Mebendazole | Infections | 11,877 |
|
Vermox 100mg/5ml oral suspension
0505010D0BBABAA
|
Vermox | Mebendazole | Infections | 107 |
|
Vermox 100mg chewable tablets
0505010D0BBAAAD
|
Vermox | Mebendazole | Infections | 79 |
|
Ovex 100mg chewable tablets
0505010D0BCAAAD
|
Ovex | Mebendazole | Infections | 35 |
|
Ovex 100mg/5ml oral suspension
0505010D0BCABAA
|
Ovex | Mebendazole | Infections | 30 |
|
Boots Threadworm Treatment 100mg chewable tablets
0505010D0BEAAAD
|
Boots Threadworm Treatment | Mebendazole | Infections | No data available |
|
Pripsen Mebendazole 100mg chewable tablets
0505010D0BDAAAD
|
Pripsen (Mebendazole) | Mebendazole | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.